Osteoporosis, bone & mineral

Reductions in Bone Mineral Density Are Apparent Early in Children With Prevalent Osteonecrosis Lesions Following Leukemia Therapy

J Bone Miner ResPublished Cross-sectional study

Authors' conclusion

Overall, one-third of children demonstrated ON after leukemia therapy. Those with ON had greater reductions in spine and hip BMD Z-scores in the first 1 and 2 years of therapy, respectively. Older age and lower hip BMD Z-scores at MRI were significantly associated with prevalent, off-therapy ON.

Study context

Population
Children with acute lymphoblastic leukemia enrolled in the STOPP study, evaluated by magnetic resonance imaging (MRI) 3.1 ± 1.3 years following therapy
Participants
86 children
Exposure
Children with vs without osteonecrosis (ON)
  • ONn = 30
  • Without ONn = 56reference
Outcome
Prevalence of osteonecrotic lesions on MRI
Follow-up
>1 year following leukemia therapy
Methodological detailsone-time multisite MRI, within STOPP study
  • One-time multisite MRI
  • Within STOPP study

Main finding

As reported in the abstract

Prevalence of ON · 3.1 ± 1.3 years following therapy

Children with confirmed ON lesions

30

35%

Total confirmed ON lesions

150

Observational data: associations, not effects.

Further findings

Pain

P = 0.841

Mean

OutcomeONWithout ONP value
LS BMD Z-score at diagnosis−1.09 (SD 1.53)−1.27 (SD 1.25)P = 0.549
Change in LS BMD Z-score · baseline to 12 months−0.31 (SD 1.02)0.13 (SD 0.82)P = 0.035
Change in hip BMD Z-score · baseline to 24 months−1.77 (SD 1.22)−1.03 (SD 1.07)P = 0.045
Total hip BMD Z-score at MRI · time of MRI−0.98 (SD 0.95)−0.28 (SD 1.06)P = 0.010
TB BMD Z-score at MRI · time of MRI−1.36 (SD 1.10)−0.48 (SD 1.50)P = 0.018

Factors independently associated with ON (multivariable models)

Older age at diagnosis: OR
1.57 (95% CI 1.15-2.13; p = 0.004)
Hip BMD Z-score at MRI: OR
2.23 (95% CI 1.02-4.87; p = 0.046)

Original publication

Reductions in Bone Mineral Density Are Apparent Early in Children With Prevalent Osteonecrosis Lesions Following Leukemia Therapy. J Bone Miner Res. Published 10 July 2023. doi:10.1002/jbmr.4870

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.